Incomplete Abortion Clinical Trial
Official title:
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
In this study, we will compare the safety and efficacy of 400 mcg sublingually administered misoprostol alone to standard surgical care for the treatment of incomplete abortion. This study will provide important data on the role of misoprostol in health services offering an array of treatments for incomplete abortion. Women could significantly benefit from a non-invasive treatment option for incomplete abortion. While safe surgical services are becoming more widespread, there is still a serious risk of complications from these procedures. Especially in developing countries, infection, hemorrhage and uterine damage are still too common. Medical treatment of incomplete abortion using misoprostol would be a tremendous step to reducing morbidity and mortality due to abortion complications.
Status | Completed |
Enrollment | 1000 |
Est. completion date | November 2009 |
Est. primary completion date | November 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Uterine size no larger than 12 weeks LMP at time of presentation for care. - Past or present history of vaginal bleeding during pregnancy. - Open cervical os. - If ultrasound used evidence of incomplete abortion with substantial debris in the uterus. - All women would have been advised to have surgical evacuation of the uterus if misoprostol was not available. - General good health. - Willing to provide contact information for purposes of follow-up. - Also in Egypt: 21 years of age or over or parental permission (there is no minimum age requirement in Niger, Mauritania and Senegal). Exclusion Criteria: - Contraindications to study drug - Signs of severe infection, defined as at least one of the following: 1) foul smelling discharge, 2) fever > 38 degrees C , 3) uterine tenderness - Hemodynamic disturbances (pulse >110/min and systolic bp <100) - Have an IUD in place; (the IUD may be removed making the woman eligible) - Suspected ectopic pregnancy |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Burkina Faso | Dandé District Hospital/Ziniaré District Hospital | Dande/Ziniare | |
Egypt | El-Galaa Teaching Hospital | Cairo | |
Egypt | Shatby Maternity Hospital/Alexandria University | Shatby, Alexandria | |
Mauritania | Cheikh Zayed Hospital | Nouakchott | |
Niger | Maternite Issaka Gazobi | Niamey | |
Senegal | Centre de Sante Le Roi Baudouin | Guediawaye |
Lead Sponsor | Collaborator |
---|---|
Gynuity Health Projects |
Burkina Faso, Egypt, Mauritania, Niger, Senegal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Complete abortion without recourse to surgical intervention. | follow up visit 7 days after initial treatment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01939457 -
400mcg Sublingual Misoprostol as First Line Treatment
|
N/A | |
Recruiting |
NCT05342467 -
Gemeprost Versus Dinoprostone in First Trimester Miscarriages
|
Phase 2 | |
Completed |
NCT00674232 -
Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment
|
N/A | |
Completed |
NCT02707653 -
Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research
|
N/A | |
Not yet recruiting |
NCT05343546 -
Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion
|
N/A | |
Recruiting |
NCT01775917 -
The Role of Uterine Artery Doppler Parameters in the Management of Retained Products of Conception.
|
N/A | |
Completed |
NCT01539408 -
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria
|
Phase 1 | |
Completed |
NCT03622073 -
Misoprostol Treatment of Mid Trimester Incomplete Abortion by Midwives and Doctors in Uganda.
|
N/A | |
Completed |
NCT01743508 -
Misoprostol Treatment of Incomplete Abortion by Midwives and Physicians in Uganda
|
N/A |